Fig. 2From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseGeneration of soluble Aβ fibrils from amyloid precursor protein [2]Back to article page